Sector pending / Hospital and Medical Service PlansUpdated 2026-05-10 22:07 UTC

FRA/7QD stock hub

FRA/7QD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/7QDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/7QDFRA/7QD

—

Loading chart…

In the news

Latest news · FRA/7QD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E31.9

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-16.9

P25 n/aP50 n/aP75 n/a

ROIC-10.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/7QD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

152

Groups with data

Currency

USD

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	724
Employees Change	18%
Employees Change Percent	3.26
Enterprise value	EUR 1.2B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Hospital and Medical Service Plans
Last refreshed	2026-05-10
Market cap	EUR 1.4B
Price	EUR 2.48
Price currency	EUR
Rev Per Employee	2,647,859.71x
Sic	6324
Symbol	fra/7QD
Website	https://www.cloverhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.54%
EV Earnings	-25.29x
EV/FCF	26.4x
EV/Sales	0.67x
FCF yield	3.39%
Forward P/E	31.92x
P/B ratio	4.74x
P/S ratio	0.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-2.58%
EBITDA Margin	-2.56%
FCF margin	2.47%
Gross margin	18.36%
Gross Profit	EUR 351.9M
Net Income	EUR -49.4M
Pretax Margin	-2.58%
Profit Margin	-2.58%
Profit Per Employee	EUR -68,211
ROA	-5.55
Roa5y	-23.26
ROCE	-15.76
ROE	-16.86
Roe5y	-95.53
ROIC	-10.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-16.48%
Cagr3y	53.73%
Revenue Growth	48.69x
Revenue Growth Q	62.05x
Revenue Growth3 Y	-9.57x
Revenue Growth5 Y	25.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 3.45
Assets	EUR 605.1M
Cash	EUR 176.5M
Equity	EUR 294.4M
Liabilities	EUR 310.8M
Net Cash	EUR 150.3M
Net Cash By Market Cap	EUR 10.76
Net Cash Growth	11.47%
Net Debt Equity	EUR -0.51
Net Debt FCF	EUR -3.18
Tangible Book Value	EUR 291.8M
Tangible Book Value Per Share	EUR 0.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.33
Net Working Capital	EUR -53.6M
Quick ratio	1.21
Working Capital	EUR 96.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.19%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-16.47%
200-day SMA	2.14
3Y total return	263.42%
50-day SMA	1.78
50-day SMA vs 200-day SMA	50under200
All Time High	10.1
All Time High Change	-75.45%
All Time High Date	2021-07-06
All Time Low	0.57
All Time Low Change	333.57%
All Time Low Date	2024-04-23
ATR	0.1
Ch YTD	21.45
High	2.48
High52	3.59
High52 Date	2025-10-27
High52ch	-30.82%
Low	2.32
Low52	1.41
Low52 Date	2026-04-02
Low52ch	75.89%
Ma50ch	39.09%
Price vs 200-day SMA	15.73%
RSI	80.07
RSI Monthly	52.23
RSI Weekly	61.64
Sharpe ratio	0.18x
Sortino ratio	0.36
Total Return	-5.19%
Tr YTD	21.45
Tr1m	51.22%
Tr1w	11.21%
Tr3m	44.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -49.4M
Operating margin	-2.58

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	405,908,789%
Shares Insiders	22.08%
Shares Institutions	24.46%
Shares Qo Q	0.96%
Shares Yo Y	5.19%
Short Ratio	7.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -30.3M
Average Volume	661x
Bv Per Share	0.56
CAPEX	EUR -2.4M
Ch1m	51.22
Ch1w	11.21
Ch1y	-16.47
Ch3m	44.35
Ch3y	263.4
Ch6m	7.92
Change	2.48%
Change From Open	6.9
Close	2.42
Days Gap	-4.13
Earnings Date	2026-05-06
EBIT	EUR -49.4M
EBITDA	EUR -49.2M
EPS	EUR -0.1
F Score	3
FCF	EUR 47.3M
FCF EV Yield	3.79x
Financing CF	-25,590,554
Fiscal Year End	December
Founded	2,014
Investing CF	-8,605,351
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Ma150	2.07
Ma150ch	19.98%
Ma20	2.01
Ma20ch	23.51%
Net CF	15,460,490
Next Earnings Date	2026-08-05
Open	2.32
P FCF Ratio	29.51
P OCF Ratio	28.12
Position In Range	100
Ppne	5,854,329.6
Price Date	2026-05-08
Ptbv Ratio	4.78
Relative Volume	12.79x
Revenue	1,917,050,432x
SBC By Revenue	4.05x
Share Based Comp	77,615,544
Tr6m	7.92%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/7QD pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/7QD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/7QD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+24.5%

Share of float held by funds and institutions

Insider ownership

+22.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/7QD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

80.1

Above 70: short-term overbought

Price vs 200-day MA

+15.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.18

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/7QD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/7QD stock rating?

fra/7QD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/7QD analysis?

The full report lives at /stocks/fra/7QD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/7QD?

The latest report frames fra/7QD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/7QD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.